BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 8232232)

  • 1. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
    Wilcox RA; Whitham EM; Liu C; Potter BV; Nahorski SR
    FEBS Lett; 1993 Dec; 336(2):267-71. PubMed ID: 8262243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
    Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions between inositol tris- and tetrakis-phosphates. Effects on intracellular Ca2+ mobilization in SH-SY5Y cells.
    Gawler DJ; Potter BV; Gigg R; Nahorski SR
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):163-7. PubMed ID: 1645528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of inositol 1,3,4,5-tetrakisphosphate on inositol 2,4,5-triphosphate-stimulated Ca2+ release do not involve direct interaction of inositol 1,3,4,5-tetrakisphosphate with inositol triphosphate-binding sites.
    Loomis-Husselbee JW; Cullen PJ; Dreikausen UE; Irvine RF; Dawson AP
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):811-6. PubMed ID: 8615774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S
    Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inositol 1,3,4,5-tetrakisphosphate-induced release of intracellular Ca2+ in SH-SY5Y neuroblastoma cells.
    Gawler DJ; Potter BV; Nahorski SR
    Biochem J; 1990 Dec; 272(2):519-24. PubMed ID: 2176465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor.
    Burford NT; Nahorski SR; Chung SK; Chang YT; Wilcox RA
    Cell Calcium; 1997 Apr; 21(4):301-10. PubMed ID: 9160166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol tetrakisphosphate-induced sequestration of Ca2+ replenishes an intracellular pool sensitive to inositol trisphosphate.
    Hill TD; Boynton AL
    J Cell Physiol; 1990 Jan; 142(1):163-9. PubMed ID: 2298819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium release activity and metabolism of inositol 1,4,5-trisphosphate in T cells. Modulation by novel inositol 1,4,5-trisphosphate 5-phosphatase inhibitors.
    Ward SG; Lampe D; Liu C; Potter BV; Westwick J
    Eur J Biochem; 1994 Jun; 222(2):515-23. PubMed ID: 8020489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR
    Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselectivity of Ins(1,3,4,5)P4 recognition sites: implications for the mechanism of the Ins(1,3,4,5)P4-induced Ca2+ mobilization.
    Wilcox RA; Challiss RA; Baudin G; Vasella A; Potter BV; Nahorski SR
    Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):191-4. PubMed ID: 8363572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic muscarinic stimulation of SH-SY5Y neuroblastoma cells suppresses inositol 1,4,5-trisphosphate action. Parallel inhibition of inositol 1,4,5-trisphosphate-induced Ca2+ mobilization and inositol 1,4,5-trisphosphate binding.
    Wojcikiewicz RJ; Nahorski SR
    J Biol Chem; 1991 Nov; 266(33):22234-41. PubMed ID: 1657992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular interactions of endogenous D-myo-inositol phosphates with the intracellular D-myo-inositol 1,4,5-trisphosphate recognition site.
    Lu PJ; Gou DM; Shieh WR; Chen CS
    Biochemistry; 1994 Sep; 33(38):11586-97. PubMed ID: 7918372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.